

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+1.42%
+4.00%
+1.50%
+2.86%
-1.82%
HQY
HealthEquity Co
$96.92
Strengths

Earnings are forecast to grow

Expands stock buyback program
Risk Analysis

Investors losing their confidence
Chart
$96.53 (+0.40%)
$98.98 (-2.08%)
$103.76 (-6.59%)
$97.95 (-1.05%)
HQY has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

HQY overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors losing their confidence

Expands stock buyback program
Future
Future

Earnings are forecast to grow
![]()
HQY Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
HQY Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayHQY Earnings
The TTM reflects 12-month period, providing review of HQY financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is HQY current stock price?
What are HQY stock strengths?
What risks are associated with HQY stock?
When is HQY next earnings report?
What is HQY market cap and volume?
What is HQY's current Stock IQ?
Should I buy HQY stock right now?
Is HQY a Strong Buy right now?
What does a 'Strong Buy' rating mean for HQY?
What does a 'Strong Sell' rating mean for HQY?
What factors influence HQY's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+1.42%
+4.00%
+1.50%
+2.86%
-1.82%
HQY
HealthEquity Co
Current Price
$96.92
Stock Insights
Strengths

Earnings are forecast to grow

Expands stock buyback program
Risk Analysis

Investors losing their confidence
Chart
$96.53 (+0.40%)
$98.98 (-2.08%)
$103.76 (-6.59%)
$97.95 (-1.05%)
HQY Analysts Opinion
HQY Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors losing their confidence

Expands stock buyback program
Future
Future

Earnings are forecast to grow
![]()
HQY Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
HQY Street view is extremely bullish and have positive views on the near-term outlook
HQY has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Average key support and resistance price levels.
HQY Earnings
The TTM data reflects the most recent 12-month period, providing overview of HQY financial performance.
HQY Financial Health
The company financial health has moderately improved over the past year
Financial Score
HQY Latest Analysis
HQY Expands Access With GLP-1 Telehealth & Direct HSA Platforms. HealthEquity rolls out GLP-1 telehealth and direct HSA enrollment platforms targeting affordability and growth amid rising healthcare costs and regulatory expansion.
Mon Oct 20, 2025
Heres Why HealthEquity (HQY) is a Strong Growth Stock. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.
Fri Oct 17, 2025
Reasons to Add HealthEquity Stock to Your Portfolio for Now. HQYs strong Q2 expanding HSAs and AI-driven efficiencies highlight its growth momentum despite data security risks.
Thu Oct 16, 2025
HealthEquity launches GLP-1 telehealth platform.
Tue Oct 14, 2025
HealthEquity EVP Sold $157K In Company Stock. A substantial insider sell was reported on October 8 by ) based on the recent SEC filing.United States Securities and Exchange Commission on Wednesday. The transaction'.s total worth stands at $157102.HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services personalized benefit information the ability to earn wellness incentives and investment advice to grow
Thu Oct 9, 2025
Keybanc Maintains HealthEquity (HQY) Overweight Recommendation. Fintel reports that on October 8 2025 Keybanc maintained coverage of HealthEquity (NasdaqGS:HQY) with a Overweight recommendation. Analyst Price Forecast Suggests 35.21% Upside
Thu Oct 9, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.